NTEC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NTEC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-04-26), Intec Parent's share price is $9.63. Intec Parent's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2021 was $-10.53. Hence, Intec Parent's Price-to-Free-Cash-Flow Ratio for today is N/A.
The historical rank and industry rank for Intec Parent's Price-to-Free-Cash-Flow or its related term are showing as below:
Intec Parent's Free Cash Flow per Share for the three months ended in Mar. 2021 was $-3.90. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-10.53.
The historical data trend for Intec Parent's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intec Parent Annual Data | |||||||||||||||||
Trend | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | |||||||||
Price-to-Free-Cash-Flow | Get a 7-Day Free Trial | - | - | - | - | - |
Intec Parent Quarterly Data | ||||||||||||||||||||
Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | |
Price-to-Free-Cash-Flow | Get a 7-Day Free Trial | - | - | - | - | - |
For the Biotechnology subindustry, Intec Parent's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Intec Parent's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Intec Parent's Price-to-Free-Cash-Flow falls into.
Intec Parent's Price-to-Free-Cash-Flow ratio for today is calculated as
Price-to-Free-Cash-Flow Ratio | = | Share Price | / | Free Cash Flow per Share (TTM) |
= | 9.63 | / | -10.534 | |
= | N/A |
Intec Parent's Share Price of today is $9.63.
Intec Parent's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.53.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Price-to-Free-Cash-Flow Ratio | = | Market Cap | / | Free Cash Flow |
Intec Parent (NAS:NTEC) Price-to-Free-Cash-Flow Explanation
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Thank you for viewing the detailed overview of Intec Parent's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Walt Addison Linscott | officer: Chief Business Officer | 1860 MONTREAL ROAD, TUCKER GA 30084 |
Nir Sassi | officer: Chief Financial Officer | 3 ELUL STREET, APT. 6, MODIIN L3 7176397 |
Nadav Navon | officer: Chief Operating Officer | 18 LEA IMENU STREET MODIIN L3 7177945 |
Anthony J Maddaluna | director | PFIZER INC. ATTN CORPORATE SECRETARY, 235 RAST 42ND STREET, NEW YORK NY 10017 |
William B Hayes | director | 231 MAPLE AVENUE, BURLINGTON NC 27215 |
Roger Pomerantz | director | 711 HARVEST HILL ROAD, CHALFONT PA 18914 |
Hila Karah | director | 9 HALAMISH STREET, CAESAREA INDUSTRIAL PARK, CAESAREA L3 38900 |
John W Kozarich | director | 10275 SCIENCE CENTER DR, SAN DIEGO CA 92121 |
Jeffrey A Meckler | director, officer: Chief Executive Officer | 740 BROADWAY, 9TH FLOOR, NEW YORK NY 10003 |
R Michael Gendreau | officer: Chief Medical Officer | 4350 EXECUTIVE DRIVE SUITE 325 SAN DIEGO CA 92121 |
Dexcel Pharma Technologies Ltd. | 10 percent owner | 1 DEXCEL STREET, OR AKIVA L3 3060000 |
Dan Oren | 10 percent owner | 1 DEXCEL STREET, OR AKIVA L3 30600000 |
Gil Bianco | director | 7 HAORANIM STREET BAZRA L3 60944 |
From GuruFocus
By PRNewswire PRNewswire • 09-25-2019
By PRNewswire PRNewswire • 02-25-2020
By PRNewswire PRNewswire • 05-12-2020
By PRNewswire PRNewswire • 12-11-2019
By PRNewswire PRNewswire • 07-22-2019
By PRNewswire PRNewswire • 08-03-2021
By PRNewswire PRNewswire • 01-31-2020
By PRNewswire PRNewswire • 09-15-2020
By PRNewswire PRNewswire • 04-28-2021
By PRNewswire PRNewswire • 05-11-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.